Fibroblast Activation Protein Imaging, An Issue of PET Clinics

In this issue, guest editors bring their considerable expertise to this important… Read more

Purchase options

Info / Buy

In this issue, guest editors bring their considerable expertise to this important topic.

Contains 16 practice-oriented topics including fibroblast activation protein inhibitor (FAPI) PET imaging in pancreatic cancer; fibroblast activation protein inhibitor (FAPI) PET imaging in colorectal cancer; fibroblast activation protein inhibitor (FAPI) cardiac imaging; fibroblast activation protein inhibitor (FAPI) PET/CT in gastric cancer; and more.
Provides in-depth clinical reviews on fibroblast activation protein imaging, offering actionable insights for clinical practice.
Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.

PET and CT radiologists

Advanced Fibroblast Activation Protein-Ligand Developments: FAP Imaging Agents: A Review of the Structural Requirements

Fibroblast Activation Protein Inhibitor PET in Pancreatic Cancer

The Diagnostic Value of Fibroblast Activation Protein Imaging in Hepatocellular Carcinoma and Cholangiocellular Carcinoma

Fibroblast Activation Protein Inhibitor PET Imaging in Head and Neck Cancer

Fibroblast Activation Protein Inhibitor-PET Imaging in Colorectal Cancer

Fibroblast Activation Protein Inhibitor PET/CT in Gastric Cancer

Current Status of Fibroblast Activation Protein Imaging in Gynecologic Malignancy and Breast Cancer

Fibroblast Activation Protein Inhibitor (FAPI)-PET Imaging in Sarcoma

Fibroblast Activation Protein Inhibitor Theranostics: The Case for Use in Sarcoma

Radiation Therapy Planning Using Fibroblast Activation Protein Inhibitor

Imaging Fibrosis

Cardiac Applications of Fibroblast Activation Protein Imaging

Fibroblast Activation Protein Inhibitor Theranostics: Preclinical Considerations

Fibroblast Activation Protein Inhibitor Theranostics: Preclinical Combination Treatment

Fibroblast Activation Protein Inhibitor Theranostics: Early Clinical Translation

Current State of Clinical Trials and Regulatory Approvals with Fibroblast Activation Protein Targeting Interventions